24
May

08:00 AM EDT

Drug Discovery Biology

Strategy Meeting East Coast USA 2022

The premier meeting for all East Coast USA Biology professionals

Le Meridien Cambridge

A MEETING EXPERIENCE UNLIKE ANY OTHER

Fresh Biology Insights

Tired of the same conference experience? Real discussions and genuine networking are often promised, but not always delivered.

Proventa International’s R&D Strategy Meetings are designed to avoid the pitfalls of a typical conference, by providing the right environment to make those important connections through interactive roundtable discussions, exclusive networking and keynote panel debates. Join Biology professionals from across the East Coast, in Boston MA, to discover new insights and take your company’s mission to the next level.

What makes our strategy meetings unique?

Roundtable Discussions

Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.

Unrivalled Networking

With senior delegation from big pharma and innovative biotech from across the East Coast, you can network with peers from different locations, all in one place.

Personalised Agenda

Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.

Solutions to your Problems

We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.

Industry Researched Topics

We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.

Senior Decision Makers

The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.

Become an official strategy meeting partner

Whatever your business needs, we can help. Get in touch for partnering opportunities

I’D LIKE TO PARTNER

Press play to hear what your colleagues had to say...

See the full agenda and facilitator line-up

Download the strategy meeting brochure for full details

DOWNLOAD THE BROCHURE

Meet Our 2022 Facilitators

Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our Drug Discovery Biology strategy meeting.

Takako Yoshida-Moriguchi

Drug Discovery Scientist and Program Lead Sai Life Sciences

Gene Petrella

Senior Director, Discovery Business Development Sai Life Sciences Ltd

Gene Petrella is a classically trained biochemist and cell biologist who has dedicated the past 25 years to technology development and drug discovery in both biotech and large pharmaceutical companies. A co-inventor of Thermofluor® (differential scanning fluorimetry), Gene led 3 -Dimensional Pharmaceutical’s Biophysics and HTS team, helping to position 3DP for a successful IPO and big pharma collaboration.
At the Novartis Institutes for Biomedical Research Gene served as drug discovery liaison to collaborating academic institutions, co-founded and built the Target Identification Proteomics platform, and spearheaded an institute-wide effort to directly target disease-causing RNA.
Leveraging his technology and drug discovery expertise, Gene founded TargetRNA Inc., a startup deploying a novel biophysics and computational platform to discover small molecule therapeutics acting directly on RNA.
Most recently, at Wave Life Sciences Gene led platform technologies ranging from RNA editing to in vivo biology.
Gene received his BS in Biology from Rutgers University, his PhD in Biochemistry from Georgetown University School of Medicine, and conducted postdoctoral studies at Johns Hopkins University School of Medicine

Marija Tadin-Strapps

Vice President & Head, Target Sciences Pfizer

Marija Tadin-Strapps is Vice President & Head, Target Sciences (TS). In this role Marija leads efforts to generate novel drug target hypotheses in areas of emerging science utilizing human genetics, functional genomics, AI/Machine Learning, and data mining tools, as well as experimental hypotheses validation to deliver differentiated targets. TS partners with other teams across ES&I, most notably the Centers for Therapeutic Innovation (CTI) as well as disease biology and technology line teams working across disease areas of interest to Pfizer. Marija brings over 15 years of industry experience in organizations ranging from early start up and small biotech to large pharma, spanning RNA therapeutics, cell therapy, and the use of human genetics and functional genomics for new target validation, biomarker discovery and translational research across multiple disease areas. Prior to joining Pfizer, Marija was at SQZ Biotechnologies after her stint as Head of Biology at Omega Therapeutics. Before Omega, Marija worked for ten years at Merck & Co. Marija earned her B.A. degree in Biology with honors from Goucher College and her Master and Doctorate degrees in Genetics and Development from Columbia University. She has authored multiple peer-reviewed publications on the use of chemically modified siRNAs and the use of human genetics for new target discovery.

Shilpi Arora

Senior Vice President, Discovery Research Transition Bio

Sandro Belvedere

Vice President, Chemistry Avicenna Biosciences, Inc.

Svetlana Belyanskaya

Vice President, Biology Anagenex

Ann Boriack-Sjodin

Vice President, Molecular Discovery Accent Therapeutics

Brent Cezairliyan

Vice President, Biology Octagon Therapeutics

Kuan-Ju Chen

Associate Principal Scientist Insmed, Inc.

Jijun Dong

Vice President, Biologics Xilio Therapeutics, Inc.

Dr. Dong serves as Vice President, Biologics at Xilio Therapeutics, where her team is developing geographically precise solutions (GPS) platform to engineer novel molecules, including cytokines and other biologics, that are designed to optimize their therapeutic index by geographically localizing their activity inside tumors. Prior to Xilio, Dr. Dong led biologics research at Cygnal Therapeutics and Alkermes Inc, developing a broad range of molecules, including cytokines, mono-specific antibodies or multi-specific antibody-cytokine fusions for immunotherapy. Prior to joining Alkermes Inc, Dr. Dong held positions of increasing responsibilities at Novartis Institutes for Biomedical Research (NIBR), leading biologic programs from early target validation to clinical candidate nomination for the treatment of cardiovascular and metabolic diseases. Dr. Dong received her Ph.D. in Biochemistry from Emory University and completed her postdoctoral training at Whitehead Institute for Biomedical Research, studying protein misfolding and its relevance in normal biology as well as in human diseases.

Larry Jolivette

Vice President, Head of DMPK Proteovant Therapeutics

Matthew Kennedy

Executive Director, Neuroscience Merck & Co.

Paul Lang

US Head In Vitro Biology, Integrated Drug Discovery Sanofi

Magdalene Moran

President & Chief Scientific Officer Caraway Therapeutics

Magdalene Moran, PhD., is a leading scientific researcher in the discovery and early development projects in multiple disease areas. She is a noted expert in the Transient Receptor Potential (TRP) family of ion channels.
Prior to joining Caraway Therapeutics, Dr. Moran was the Senior Vice President of biology at Hydra Biosciences, where she was part of the scientific team for over 15 years. She led discovery and early development projects in pain, pulmonary, CNS, and renal diseases, resulting in six development candidates in six years. In addition, Dr. Moran was the scientific representative for business development activities and coordinated the scientific advisory and medical advisory boards. Before Hydra, Dr. Moran served as a researcher in the laboratory of ion channel expert Dr. David Clapham at Children’s Hospital in Boston, where she studied the basal transcription machinery and cloned several novel ion channels.
Dr. Moran received her bachelor’s degree in biology with a concentration in neuroscience from Williams College and earned her doctorate degree in neurobiology from Harvard University.

Joe Patel

Vice President, Structural Biology Treeline Biosciences

Matthew Wagoner

Global Head, Investigative Toxicology Takeda Pharmaceuticals

Jeremy Wilbur

Senior Director Early Research, Head of Protein Science Relay Therapeutics

Here To Help

Want to know more? Interested in sponsoring the event? Need help registering your team? Just get in touch and a member of the team will be happy to help.

Quick Links

Want to find out more?

Find out more details about our Strategy Meetings and other news and events.

Europe

USA East

USA West

Webinars

Dinners & Spotlights

R&D

R&D Boston

Drug Discovery Biology Strategy Meeting East Coast – Boston 2024

Drug Discovery Biology

Strategy Meeting East Coast USA 2022

<img class="lazy" decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://proventainternational.com/wp-content/uploads/2020/12/location.png" >Le Meridien Cambridge

Fresh Biology Insights

What makes our strategy meetings unique?

Roundtable Discussions

Unrivalled Networking

Personalised Agenda

Solutions to your Problems

Industry Researched Topics

Senior Decision Makers

Become an official strategy meeting partner

Press play to hear what your colleagues had to say...

See the full agenda and facilitator line-up

Meet Our 2022 Facilitators

Takako Yoshida-Moriguchi

Gene Petrella

Marija Tadin-Strapps

Shilpi Arora

Sandro Belvedere

Svetlana Belyanskaya

Ann Boriack-Sjodin

Brent Cezairliyan

Kuan-Ju Chen

Jijun Dong

Larry Jolivette

Matthew Kennedy

Paul Lang

Magdalene Moran

Joe Patel

Matthew Wagoner

Jeremy Wilbur

Our 2022 Thought Leader

Our 2022 Co-Hosts

Here To Help

Want to find out more?

Select days you wish to attend You can add multiple days

Daily Delegate Rate includes:

VAT Excluded

Select days you wish to attend You can add multiple days

Pass includes:

VAT Excluded

About You

Your Address

About Your Company

This is required field*

Bone/Osteoporosis

Immunology

Orthopaedics

Cardiovascular

Infectious diseases

Pulmonology

CNS

Inflammation

Psychiatry

Dermatology

Internal diseases

Respiratory

Diabetes

Metabolic diseases

Rheumatology

Endocrinology

Nephrology

Surgery

ENT

Neurology

Urology

Gastroenterology

Oncology

Vaccines

Haematology

Ophthalmology

Le Meridien Cambridge